Evidence map›Paper›PMID 36555857›Full record

ArticleInternational journal of molecular sciences2022

Effects of Cardiac Stem Cell on Postinfarction Arrhythmogenic Substrate.

Ángel Arenal, Gonzalo R Ríos-Muñoz, Alejandro Carta-Bergaz, Pablo M Ruiz-Hernández, Esther Pérez-David, Verónica Crisóstomo, Gerard Loughlin, Ricardo Sanz-Ruiz, Javier Fernández-Portales, Alejandra Acosta and 8 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Therapeutic application of extracellular vesicles in human diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Ángel ArenalDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Gonzalo R Ríos-MuñozDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0003-2446-3045
Alejandro Carta-BergazDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Pablo M Ruiz-HernándezDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Esther Pérez-DavidDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0002-5331-1473
Verónica CrisóstomoCenter for Biomedical Research in Cardiovascular Disease Network (CIBERCV), 28029 Madrid, Spain.ORCID 0000-0003-1740-7029
Gerard LoughlinDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Ricardo Sanz-RuizDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0002-3370-6064
Javier Fernández-PortalesHospital San Pedro de Alcántara, 10003 Cáceres, Spain.
Alejandra AcostaDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Claudia Báez-DíazCenter for Biomedical Research in Cardiovascular Disease Network (CIBERCV), 28029 Madrid, Spain.ORCID 0000-0001-9031-2929
Virginia Blanco-BlázquezCenter for Biomedical Research in Cardiovascular Disease Network (CIBERCV), 28029 Madrid, Spain.ORCID 0000-0003-1971-919X
María J Ledesma-CarbayoDepartamento Ingeniería Electrónica, Universidad Politécnica de Madrid and CIBER-BBN, 28040 Madrid, Spain.
Miriam ParejaDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
María E Fernández-SantosDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0001-9229-0022
Francisco M Sánchez-MargalloCenter for Biomedical Research in Cardiovascular Disease Network (CIBERCV), 28029 Madrid, Spain.ORCID 0000-0003-2138-988X
Javier G CasadoCenter for Biomedical Research in Cardiovascular Disease Network (CIBERCV), 28029 Madrid, Spain.
Francisco Fernández-AvilésDepartment of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Hospital General Universitario Gregorio Marañón · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESUniversidad Complutense de Madrid · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESHospital San Pedro de Alcántara · ES

Funding

Cooperative Cardiovascular Disease Research Network RIC RD12/0042/0001European Union's H2020 Program No. 874827 (BRAVE)Instituto de Salud Carlos III PI18/01895, DTS21/00064Red de Terapia Celular from the Instituto de Salud Carlos III RD16/0011/0029, RD12/0019/0021Ricors-Red de Investigación Cooperativa Orientada a Resultados en Salud RICORS TERAV RD21.0017.0002Spanish Ministry of Science and Innovation PI10/02771, TIN2007-68048-C02-01, TIN2007-68048-C02-02, PI13-01882, PI13-00903, PI13/02858, IJCI-2014-22178, TEC2010-21619-C04-03
6 · The paper itself

Abstract

Clinical data suggest that cardiosphere-derived cells (CDCs) could modify post-infarction scar and ventricular remodeling and reduce the incidence of ventricular tachycardia (VT). This paper assesses the effect of CDCs on VT substrate in a pig model of postinfarction monomorphic VT. We studied the effect of CDCs on the electrophysiological properties and histological structure of dense scar and heterogeneous tissue (HT). Optical mapping and histological evaluation were performed 16 weeks after the induction of a myocardial infarction by transient occlusion of the left anterior descending (LAD) artery in 21 pigs. Four weeks after LAD occlusion, pigs were randomized to receive intracoronary plus trans-myocardial CDCs (IC+TM group, n: 10) or to a control group. Optical mapping (OM) showed an action potential duration (APD) gradient between HT and normal tissue in both groups. CDCs increased conduction velocity (53 ± 5 vs. 45 ± 6 cm/s, p < 0.01), prolonged APD (280 ± 30 ms vs. 220 ± 40 ms, p < 0.01) and decreased APD dispersion in the HT. During OM, a VT was induced in one and seven of the IC+TM and control hearts (p = 0.03), respectively; five of these VTs had their critical isthmus located in intra-scar HT found adjacent to the coronary arteries. Histological evaluation of HT revealed less fibrosis (p < 0.01), lower density of myofibroblasts (p = 0.001), and higher density of connexin-43 in the IC+TM group. Scar and left ventricular volumes did not show differences between groups. Allogeneic CDCs early after myocardial infarction can modify the structure and electrophysiology of post-infarction scar. These findings pave the way for novel therapeutic properties of CDCs.

Indexed as

Myocardial InfarctionTachycardia, VentricularAnimalsCicatrixHeartMyocardiumStem CellsSwinecardiosphere-derived cellselectrophysiologypost-infarction scarstem cellsventricular arrhythmiasventricular tachycardia

Identifiers

PMID36555857
PMCPMC9781106
OpenAlexW4311885425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.